Bioceltix S.A. Logo

Bioceltix S.A.

Develops stem cell-based medicinal products for veterinary use.

BCX | WAR

Overview

Corporate Details

ISIN(s):
PLBCLTX00019 (+1 more)
LEI:
259400QZD5JYK8SLZU51
Country:
Poland
Address:
Wrocław Bierutowska 57-59/BUD.III, 51-317 Wrocław

Description

Bioceltix S.A. is a biopharmaceutical company that develops stem cell-based medicinal products for veterinary use. The company focuses on creating therapies that utilize Mesenchymal Stem Cells (MSCs) as the active pharmaceutical ingredient. Its product pipeline is aimed at treating immunological and inflammatory conditions in companion animals, including dogs, cats, and horses. A key area of development includes treatments for conditions such as atopic dermatitis in dogs and degenerative joint disease.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-05-07 18:29
Informacja o liczbie akcji i głosów
Polish 74.3 KB
2024-05-07 18:29
Klauzula informacyjna o przetwarzaniu danych osobowych
Polish 174.2 KB
2024-05-07 18:29
Formularz głosowania przez pełnomocnika
Polish 160.9 KB
2024-05-07 18:29
Formularze pełnomocnictwa
Polish 115.1 KB
2024-05-07 18:29
Zestawienie zmian statutu
Polish 86.8 KB
2024-05-07 18:29
Opinia Zarządu
Polish 73.1 KB
2024-05-07 18:29
Projekty uchwał wraz z uzasadnieniem
Polish 148.9 KB
2024-05-07 18:29
Ogłoszenie o zwołaniu NWZ
Polish 145.2 KB
2024-05-07 18:29
Zwołanie NWZ na dzień 3 czerwca 2024 roku - Content (PL)
Polish 2.1 KB
2024-05-07 17:38
Przyjęcie planu budowy wielkoskalowej wytwórni komórek macierzystych i sposobu …
Polish 5.4 KB
2024-04-26 17:12
Podpisy do opinii biegłego rewidenta z badania Sprawozdania Finansowego Biocelt…
Polish 10.3 KB
2024-04-26 17:12
Opinia biegłego rewidenta z badania Sprawozdania Finansowego Bioceltix S.A. za …
Polish 2.9 MB
2024-04-26 17:12
Podpisy do Raportu okresowego rocznego Bioceltix S.A. za rok 2023
Polish 20.9 KB
2024-04-26 17:12
Raport okresowy roczny Bioceltix S.A. za rok 2023
Polish 17.3 MB
2024-04-26 17:12
Podpisy do Sprawozdania z Działalności Bioceltix S.A. za okres sprawozdawczy za…
Polish 20.9 KB

Automate Your Workflow. Get a real-time feed of all Bioceltix S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bioceltix S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bioceltix S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Corline Biomedical AB Logo
Develops heparin-based solutions for medical devices and regenerative medicine.
Sweden
CLBIO
CorMedix Inc. Logo
Biopharma firm developing therapeutics for infectious and inflammatory diseases.
United States of America
CRMD
Corvus Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing therapies for immune diseases and cancer.
United States of America
CRVS
Cosma Spolka Akcyjna Logo
Manufactures and distributes hemp and cannabis products for humans and animals.
Poland
COS
COSMO Pharmaceuticals N.V. Logo
A specialty pharmaceutical firm focused on gastroenterology, dermatology, and healthtech.
Netherlands
COPN
Cosmos Health Inc. Logo
Vertically integrated healthcare group in the nutraceutical and pharmaceutical sectors.
United States of America
COSM
Coya Therapeutics, Inc. Logo
Clinical-stage biotech developing therapies to enhance regulatory T cell function.
United States of America
COYA
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Logo
Clinical-stage biotech firm focused on regenerative medicine and immunotherapy.
United States of America
CELZ
CRESCENT BIOPHARMA, INC. Logo
Biopharmaceutical company researching and developing a pipeline of cancer therapies.
United States of America
CBIO
Crinetics Pharmaceuticals, Inc. Logo
Develops oral therapeutics for endocrine diseases and endocrine-related tumors.
United States of America
CRNX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.